Challenges and Potential for Ovarian Preservation with SERMs.

Area of Science:

• Reproductive endocrinology
• Oncology
• Pharmacology

Background:

• Tamoxifen (TAM) is a selective estrogen receptor modulator (SERM) primarily used for breast cancer treatment and prevention.
• Estrogen signaling plays a critical role in ovarian function and fertility.
• Cancer therapies like chemotherapy and radiation can cause significant ovarian damage, leading to infertility.

Purpose of the Study:

• To review the current and emerging applications of SERMs, focusing on Tamoxifen (TAM).
• To evaluate the potential of TAM for fertility preservation in cancer patients.
• To discuss the advantages and challenges associated with translating TAM for human fertility preservation.

Main Methods:

• Literature review of preclinical and clinical studies on Tamoxifen (TAM) and fertility.
• Analysis of studies investigating the mechanisms of TAM's effects on ovarian follicles.
• Examination of data on the efficacy and safety of TAM for fertility preservation.

Main Results:

• Preclinical studies demonstrate that TAM can prevent infertility and mitigate follicular loss caused by cancer treatments.
• TAM exhibits tissue-specific modulation of estrogen signaling, offering a protective effect on ovarian function.
• Evidence suggests TAM's potential as a fertility-sparing agent in oncology.

Conclusions:

• Tamoxifen (TAM) shows promise for preserving fertility in individuals undergoing gonadotoxic cancer therapies.
• Further research and clinical trials are necessary to establish optimal protocols for TAM use in human fertility preservation.
• Translating the benefits of TAM for fertility preservation presents both opportunities and challenges in clinical practice.